2023 Pitchers

Start-up Slams

The Start-up Slams showcase young promising companies seeking to raise a seed or a Series A financing round.

Sponsored by: 

Discover below the start-up projects that will be presented during BioFIT 2023:

Tuesday, December 12th | 9.00 – 10.30 am

ONCOLOGY

ORAKL ONCOLOGY
Cancer | Techbio | Drug discovery and development

NASASBIOTECH
Glioblastoma | Medical Device | Treatment

CASINVENT PHARMA
Targeted therapy & resistance | Pancreatic cancer Gemcitabine | AML Venetoclax resistance

GLIOCURE
Anti-mitotic peptide | Taxane resistant tumors | TUBB3

REACT THERAPEUTICS
Oncology | Multi-Drug Resistance | New Chemical Entities

ONCOSEMA
Cancer monitoring | Circulating Tumor Cells | Blood test for oncology

DRUG DISCOVERY

URANIA THERAPEUTICS 
Genetic disease | Cancer | Small molecule

Tuesday, December 12th | 2.00 – 3.00 pm

INFLAMMATION

SURVIVX
Sepsis | Immunomodulation | Adjuvant

PHIALOGICS
Autoimmune disease | Biologics | Immune tolerance

NUMA HEALTH
Preventive medicine | Personalized medicine | Bio-analytics

PERIOTRAP PHARMACEUTICALS
Microbiome | Small molecule | Healthcare

Tuesday, December 12th | 3.15 – 4.30 pm

CNS

AMYL THERAPEUTICS
Neurodegenerative diseases | Amyloidosis | Multi-targets binding

INNOVADE THERAPEUTICS
Depression | Rapid Acting Antidepressant | Synaptic Plasticity

AGENT
Alzheimer’s Disease | Blood Test | Precision Medicine

MEDJEDUSE
Traumatic spinal cord injury | Tissue engineering biomaterial | Sensory-motor recovery

LACTABICO
Peptides | Anxiety disorders | Metabolic disorders

Wednesday, December 13th | 9.00 – 10.00 am

DRUG DISCOVERY

STH BIOTECH
Bioproduction | Therapeutic cannabis| Metabolic engineering

REFOXY PHARMACEUTICALS
Idiopathic Pulmonary Fibrosis | Ageing-diseases | FOXO3

ORIA BIOSCIENCE
New intracellular targets | Organelles | High Throughput Screening

GENERARE
Synthetic biology | Bioinformatics | Natural products

DIAGNOSTIC

MARX BIOTECHNOLOGY
Health Care | Life Sciences | Diagnostics

Wednesday, December 13th | 10.30 am – 12.15 pm

CARDIOVASCULAR & METABOLIC DISEASES

EXADEX-INNOV 
Chronic metabolic diseases | Obesity | Cell therapy

TECHNOLOGY PLATFORMS

SEABELIFE BIOTECH
First in class small molecule | Cell death inhibitor | Plateform Technology

EVERSYN
 
Biobetters & Biosimiliars | Glycoengineering | Oligosaccharides

MT-ACT
NCEs | First in class | Cardiovascular

EPHYRA 
Sponge RNA | miRNA | Snowflake RNA (sfRNA)

DRUG DELIVERY

NANOREVIV
Drug Delivery Platform | Antibiotics | Bacterial resistances

APILLET
Enteric encapsulation/coating | Nutraceuticals & pharmaceutica | Natural materials

THERALIA
Drug delivery | Personalized medicine | Targeted antibiotics

Wednesday, December 13th | 2.00 – 3.15 pm

IMMUNOLOGY

BYORNA
RNA | Vaccine| Cancer

LOVALTECH
Nasal vaccines | Universal protein vaccine | Mucosal immunity

IMMUNEWATCH
Immunology | T cells | AI

ONCO-IMMUNOLOGY

MODIBLAST PHARMA
Leukemia | Immunomodulation | Dendritic Cell

ONCOBONE VENTURES
Bone metastasis | Immunotherapy | Preclinical testing

Collaborative and licensing opportunity presentations

The Collaborative and Licensing Opportunity Presentations showcase early-stage technologies from TTOs, universities, research institutes and companies.

Co-organised by: 

Discover below the technologies that will be presented during BioFIT 2023

Tuesday, December 12th | 9.00 – 10.30 am

INFECTIOUS DISEASES

NANOREVIV – STAPH-EX 
Lipid nano-capsules Platform | Antibiotics | Bacterial Resistance

AATEC MEDICAL – AAT
Inflammation | Respiratory | Inhalation

LILLE UNIVERSITY/ INSERM – CANDIDIASIS DIAGNOSIS
Candidiasis | Diagnosis | Monoclonal antibody

BIOASTER – COLICIN/IMMUNITY TECHNOLOGY 
Multiplexing | Immunoassay | Diagnostic

G.ST ANTIVIRALS – 2-DEOXYGLUCOSE TREATMENT
Respiratory viral infections | 2-deoxyglucose | Spray and nebulizer 

Tuesday, December 12th | 5.00 – 6.15 pm

CELL & GENE THERAPY

FONDAZIONE TELETHON ETS – 3D CELL CULTURE 
3D cell culture | Gene Therapy | Nichioids

FONDAZIONE TELETHON ETS – CASWITCH 
Gene circuit | Biosensor | Inducible gene expressio (no leakiness)

FONDAZIONE TELETHON ETS – IL-1RA GENE  THERAPY 
Gene Therapy | IL-1RA | Systemic Autoinflammatory Diseases

FONDAZIONE TELETHON ETS – TOLEROGENIC DC TECHNOLOGIES 
Tolerogenic Dendritic Cells | Autoimmune diseases | Cell Therapy

CNS

CILCARE – AUDITORY MEASUREMENTS
Auditory | Biomarker | CNS

KVANTIFY – DRUG DISCOVERY TOOL 
Drug discovery | CNS | Small molecule

UNIVERSITY OF ANTWERP – INEUROVIR
Viral infection | Neurodegenerative | High throughput screening

IOCB TECH 
Neurosteroids | Neuropathic pain | Epilepsy

 

Wednesday, December 13th | 9.00 – 10.00 am

ONCOLOGY

ERASMUS MC – CHROMSTRETCH
DNA replication | Replication stress | Cancer

MINOS BIOSCIENCES – SINGLE – CELL ANALYSIS 
Oncology / Immuno-oncology | Single-cell functional analysis | Multi-omic analysis

SAN RAFFAELE UNIVERSITY AND RESEARCH HOSPITAL – CAR/TCR T CELL THERAPY  
CAR | Adoptive cell therapy | Cancer

UNIVERSITY OF GRENOBLE ALPES (UGA) – TERG
Glioma | Antisense oligonucleotide | Sensitization

AKRIBION GENOMICS – G-DASE E
Programmable anti-cancer drugs | RNA biomarkers | Head & neck cancer

Animal Health Presentations

The Animal Health Presentations focus on innovations in relation to animal well-being and health.

Co-organised by: 

Discover the animal health projects that will be presented during BioFIT 2023

Tuesday, December 12th | 5.00 – 6.00 pm

ANIMAL HEALTH

VETBIOLIX 
Cathepsin-K Inhibitor | Adenosin-A3 Agonist | 5-HT4 Agonist

MI:RNA
Blood microRNA | Artificial Intelligence | Early disease diagnosis

VIRCO
Antiviral | Corrol | Poxyvirus / Herpes virus 

MYOMU   
Sarcopenia | Natural compound | NCE

LUCKY  
Probiotic | Anti-proliferative | Pets

Jury members

Alexandre Breda, Biotech Start-up Manager, Eurasanté
Gary Breit, CEO, Breit Ideas LLP
Vincent Brichard, Venture Partner, EQT Life Sciences
Zuzanna Brzosko, Senior Director, Corporate Strategy & External Innovation, Eli Lilly and Company
Ivan Burkov, Principal, Inkef
Florence Dal Degan, Senior Director, External Innovation, Rare Diseases and Neuroscience, Ipsen
Isabelle Dupin-Roger, Director, R&D External Innovation I Neuroscience and Immuno-inflammation, Servier
Dorothée Gueras Tricart
, Head of Biotech division, Eurasanté

Monique Guis, External Innovation Immunology Director, Sanofi
Frank Hensel, Principal, High-Tech Gründerfonds
Dmitrij Hristodorov, Partner, Forbion
Lydia Kalafateli, Venture Developer, NLC Health
Alexandre Laly, Customer Application Consultant – Emerging Biotech, Merck
Esther Lange, Industry Liaison Manager, Ascenion
Marie-Ange N’Zoutani, Head of Acceleration office Sanofi Partnering, Sanofi
Richard Reschen, Associate Director, BD&L Europe, MSD
Olaf Ritzeler, BD&L, Director, Rare Diseases External Innovation / GLOBAL, Sanofi
Corinne Szilagyi, Senior Partner, Biotech Développement Conseils & Member of the Business Development Committee, France Biotech
Kristin Thompson, VP, Chief Business Officer, eureKARE
Joachim Vogt, Director, Search and Evaluation, Western Europe, AbbVie
Ulrich Zugel, Senior Director Emerging Science & Innovation Lead – Inflammation & Immunology Europe, Pfizer
Jean-Christophe Audonnet
Jean-Louis Hunault, President, SIMV
Theo Kanellos, Director Business Development and comercial Alliances, Zoetis
Jean-Pascal Marc, Corporate Product Innovation Director, Virbac
Edouard Timsit, Senior Innovation Scientist, Ceva Santé Animale

Sponsors

Contact

Vincent Tavernier

Scroll to Top
  • No products in the cart.